Basit öğe kaydını göster

dc.contributor.authorGungor, IU
dc.contributor.authorBeden, U
dc.contributor.authorErkan, D
dc.date.accessioned2020-06-21T15:36:47Z
dc.date.available2020-06-21T15:36:47Z
dc.date.issued2005
dc.identifier.issn1082-3069
dc.identifier.urihttps://doi.org/10.3928/1542-8877-20050701-19
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21043
dc.descriptionWOS: 000232140900017en_US
dc.descriptionPubMed: 16156157en_US
dc.description.abstractA rare side effect of betamethasone applied subconjunctivally is described. A 51-year-old man who had undergone penetrating keratoplasty in his left eye 2 months previously developed graft rejection and was treated by subconjunctival injection of betamethasone. Within 2 weeks, the patient complained of conjunctival hyperemia and irritation. Biomicroscopic examination revealed conjunctival and subconjunctival necrosis with white necrotic tissue at the subconjunctival corticosteroid injection site. Simple debridement and primary wound closure of the involved area resulted in complete healing. Ophthalmologists should be aware that subconjunctival. injection of betamethasone may cause conjunctival necrosis.en_US
dc.language.isoengen_US
dc.publisherSlack Incen_US
dc.relation.isversionof10.3928/1542-8877-20050701-19en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleConjunctival necrosis due to subconjunctival injection of betamethasone in treatment of graft rejection after penetrating keratoplastyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume36en_US
dc.identifier.issue4en_US
dc.identifier.startpage348en_US
dc.identifier.endpage349en_US
dc.relation.journalOphthalmic Surgery Lasers & Imagingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster